GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease.
Yi-Sun YangHsin-Hung ChenChien-Ning HuangChung Y HsuKai-Chieh HuChia-Hung KaoPublished in: Diabetes care (2022)
Longer use and higher dose of GLP-1 RAs were associated with a decreased risk of hospitalization for ischemic stroke among Asian patients with T2D who did not have established atherosclerotic cardiovascular diseases, but who did have dyslipidemia or hypertension.